Farnam Financial’s Bio-Rad Laboratories Class A BIO Stock Holding History
Bought
Maintained
Sold
Other funds holding BIO
Farnam Financial's BIO Position: Q3 2026 in Review
Farnam Financial held its Bio-Rad Laboratories Class A (BIO) position steady in Q3 2026 at 773 shares worth $273K. The position accounts for 0.2% of the portfolio, ranked #52.
Farnam Financial first reported a position in BIO in Q3 2024 and has held it in 9 quarters since. The position peaked at $2.27M in Q3 2024. 415 funds tracked by Wall St. Rank hold BIO as of Q3 2026.
- Farnam Financial held 773 shares of Bio-Rad Laboratories Class A worth $273K as of Q3 2026.
- Farnam Financial left its Bio-Rad Laboratories Class A share count unchanged in Q3 2026.
- Bio-Rad Laboratories Class A made up 0.2% of Farnam Financial's portfolio in Q3 2026, its #52 holding.
- Farnam Financial first reported a position in Bio-Rad Laboratories Class A in Q3 2024 and has held it in 9 quarters since.
- Farnam Financial's Bio-Rad Laboratories Class A position peaked at $2.27M in Q3 2024.
- 415 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q3 2026.
Based on Farnam Financial's 13F filing for Q3 2026, filed 21 Oct 2026.